Forecast & Rating2 analysts currently cover Biocytogen, of which 2 give a positive rating. The average price target is ¥116.50, about 9.5% upside from the current price of ¥106.37. Coverage is limited, so the data is for reference only. Data as of Jul 6, 2026; this does not constitute investment advice.
Jul 4, 2026
Price forecast
¥116.509.52%
Forecast & RatingBuy
2analysts
Strong buy50.00%
Buy50.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
1
Buy
1
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 30, 2026
Forecast met94.6%
Stock price$106.37
Average forecast price$116.5
Highest forecast price$117
Lowest forecast price$117
Average forecast price
$116.5
Highest forecast price
$117
Lowest forecast price
$117
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.